期刊文献+

糖尿病高风险人群糖化血红蛋白与微血管并发症的关系 被引量:47

Relationship between HbA1c and microvascular complications in high-risk populations of diabetes
原文传递
导出
摘要 目的 探讨在广州地区的糖尿病高风险人群中HbA1c与糖尿病微血管并发症之间的关系,并评价其对糖尿病的诊断价值。方法对208例糖尿病高风险患者进行HbA1c血精、眼底彩色照相及微量白蛋白尿测定。以受试者工作特征(ROC)曲线比较HbA1c、空腹血糖(FPG)、餐后2hm糖(2hPG)的诊断效果。结果高风险人群中糖尿病视网膜病变患病率为14.9%,微量白赁白尿患病率为12%HbA1c、FPG和2hPG分别为5.8%、7.0mmol/L和10.9mmol/L时视网膜病变的发病率显著增加:HbA1c FPG和2hPG分别为5.8%、6.4mmol/L和107mmol/L时微量白蛋白尿发病率明显增加:结论HbA1c为5.8%时糖尿病高风险人群微血管并发症患病率显著增加,HbA1c和2hPG判断做血管并发症的效果尤明显差异。FPG相对偏低。 Objective To explore the association of HbA1c with microvascular complicatinns,and to evaluate the diagnostic value of HbA1c in diabetes mellitus in high-risk populations of Guangzhou. Methods HbA1c, blood glucose, fundus photography, and microalbuminuria were detected in 208 permanent residents with high-risk factors of diabetes. The receiver operating characteristic(ROC) curves were used to estimate the area of HbA1c, fasting plasma glucose ( FPG ) , postprandial 2 h plasma glucose ( 2hPG ) under the crone for discriminating nficrovascular complications. Results There were 14.9% adults suffering from diabetic retinopathy and 12% microalbuminuria in high risk populations of diabetes. The optimal cutoff points of HbA1c, FPG, and 2hPG in detecting retinopathy were 5.8c/c ,7.0 retool/L, and 10.9 mmol/L respectively. The thresholds for increasing prevalence of microalbuminuria were 5.8% for HbA,: ,6.4 mmol/L for FPG, and 10.7 mmol/L fnr 2hPG. Conclusions The prevalence of diabetic microvascular complications increases dramatically at the concentration of HDA1c 5.8%. As a diagnostic value for microvascular complications, there is no significant difference between HbA1c and 2hPG.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2011年第5期381-385,共5页 Chinese Journal of Endocrinology and Metabolism
基金 广东省海珠区科技计划项目(2007-Z-055)
关键词 糖化血红蛋白 微血管并发症 糖尿病:高风险人群 诊断 HbA1c Microvaseular complications Diabetes mellitus High-risk pnpulations Diagnose
  • 相关文献

参考文献19

  • 1Reynolds TM, Smellie WS, Twomey PJ, et al. Glycated haemoglobin ( A1 C ) monitoring. BMJ ,2006,333:586-588.
  • 2American Diabetes Association Standards of medical care in diabetes-- 2010. Diabetes Care,2010,33 ( Suppl 1 ) : S11 -S61.
  • 3Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004,27 : 1047-1053.
  • 4Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med ,2010,362:1090-1101.
  • 5Lindstrom J,Tuomilehto J. The Diabetes Risk Score : a practical tool to predict type 2 diabetes risk. Diabetes Care,2003,26:725-731.
  • 6Franciosi M, De Berardis G, Rossi MC, et al. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO ( Impaired Glucose tolerance and Long- Term Outcomes Observational ) study. Diabetes Care, 2005, 28: 1187-1194.
  • 7Wilson SE, Lipscombe LL, Rosella LC, et al. Trends in laboratory testing for diabetes in Ontario, Canada 1995-9005 : a polpulation-based stud),. BMC Health Serv Res,2009,9: 41.
  • 8Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(lc). Diabetes Care ,2003,26 : 8812-8851.
  • 9Tien YW, Gerald L, Rob.vn J. et al. Relation between tasting glucose and retinopathy for diagnosis of diabetes : three pupulation-based cross- sectional studies. Lancet,2008,371:736z-743.
  • 10DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotypc of patients with diabetes? Reanalysis of European epidemiological data. BMJ, 1998,317:371-375.

同被引文献361

引证文献47

二级引证文献335

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部